Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for Jones Fractures
NCT01173081Phase 4Unknown
- Sponsor
- Orthopedic ONE
- Start
- Jul 2010
- Primary completion
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Jones fracture comparing Teriparatide with Placebo (2 arms). Primary endpoint: Fracture healing. Status: unknown.
02
Drugs
teriparatide
03
Conditions
Jones fracture
Beyond the preview
Go deeper on NCT01173081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01173081.